News
Weight-loss patients voice concerns as CVS Caremark drops Zepbound coverage for Wegovy, though exceptions may exist for those ...
Millions of Americans who have dropped pounds and boosted their health using popular obesity drugs like Wegovy are facing a ...
U.S. prices for obesity-treatment pills that Eli Lilly and Novo Nordisk aim to launch next year likely will be on par with ...
Texas Attorney General Ken Paxton has sued Eli Lilly, alleging the drugmaker offered illegal incentives to providers, leading ...
GreensKeeper Asset Management, an investment management company, released its second-quarter 2025 investor letter. A copy of ...
The increase in costs could make affording medicine and health care even more expensive for people with lower incomes.
6d
Baller Alert on MSNOzempic and Zepbound Lawsuits Explode: Patients Say Popular Weight-Loss Drugs Left Them Hospitalized
More than 2,000 lawsuits are now targeting the makers of Ozempic and Zepbound, with patients claiming the drugs caused dangerous and sometimes permanent health problems. The cases, consolidated in ...
The mad rush for safe and effective obesity drugs has winners—including Eli Lilly’s Zepbound and Novo Nordisk’s Wegovy—and ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results